A Randomized Controlled Trial of Growth Hormone in Active Pediatric Crohn Disease

Abstract

The addition of GH to CTX therapy did not induce a reduction in mucosal inflammation, relative to CTX alone. However, GH was safe and effective as an adjunct to CTX for treatment of clinical disease activity and growth failure in pediatric CD.